RE: C-DIFF6 Jan 2017 12:36
Thanks, GMCC.
I would recommend anyone contacting the company if they are in any dought. I did, although wasn't in any dought, just wanted to reassure my confidence before planning my buying strategy for this year. All on track and planning rdz p3 ongoing. Lots of work to do and with the Srpt deal they have plenty dosh to run through Dec'18.
I guess no rush to pen a deal until they have p3 fully planned. As Glyn told us before, pharma's always seem to pop back up at the 11th hour with an offer. So I guess it's a waiting game on both sides. Also with the srpt deal we know our team can and will deliver results. GLA